Lexicon Pharmaceuticals, Inc. Ratios

Ratios Dec2009 Dec2010 Dec2011
Profitability
EBT Margin -873.07%-2,074.19%-6,285.29%
EBIT Margin -840.71%-1,950.24%-6,170.63%
EBITDA Margin -840.71%-1,950.24%-6,170.63%
Operating Margin -840.71%-1,950.24%-6,170.63%
Net Margin -872.12%-2,073.66%-6,285.29%
FCF Margin -835.37%-1,701.30%-4,821.20%
Efficiency
Assets Average 398.70M
Equity Average 703.36M490.45M272.30M
Invested Capital 772.36M248.16M299.01M
Asset Utilization Ratio 0.00
Leverage & Solvency
Interest Coverage Ratio -30.33-35.20-45.13
Debt to Equity 0.090.120.08
Debt Ratio 0.080.06
Equity Ratio 0.670.69
Times Interest Earned -30.33-35.20-45.13
Valuation
Enterprise Value 141.60M274.98M153.91M
Market Capitalization 298.70M486.09M435.60M
Return Ratios
Return on Sales -8.72%-20.74%-62.85%
Return on Capital Employed -0.30%
Return on Invested Capital -0.12%-0.19%
Return on Assets -0.29%
Return on Equity -0.13%-0.21%-0.43%